Category: Company News
-

argenx VYVGART Sales Rise 60% as Pipeline Readouts Approach
argenx delivered $1.5 billion in second-quarter VYVGART product sales and entered the second half with two registrational study readouts expected before year-end. Key Investor Takeaways Why ARGX Stock Is in Focus argenx SE (NASDAQ:ARGX) generated second-quarter product net sales of $1.52 billion, compared with $949 million in the same period of 2025. Total operating income…
-

FirstService Reports 2% Second-Quarter Revenue Growth as Macro Headwinds Limit Expansion
FirstService delivered modest revenue and adjusted earnings growth in the second quarter, while management warned that persistent economic pressure is likely to keep second-half top-line growth near current levels. Key Investor Takeaways Why FSV Stock Is in Focus FirstService Corporation (NASDAQ:FSV) reported second-quarter revenue of $1.45 billion, representing a 2% increase from the prior-year period.…
-

American Gold & Copper to Begin Trading Under New AGCI Ticker Following Name Change (USOTC:AGCI)
The corporate rebranding aligns the company’s public identity with its mining strategy as it advances a proposed Nevada copper-gold acquisition and prepares to become an SEC reporting company. Key Investor Takeaways Why AGCI Stock Is in Focus Everlert announced that FINRA has approved its corporate name change to American Gold & Copper Inc. along with…
-

Zhengye Biotechnology Says No Material Events Behind Unusual Trading Activity (NASDAQ:ZYBT)
The company issued a statement after a sharp increase in trading volume, saying it is unaware of any undisclosed developments that would explain the recent market activity. Key Investor Takeaways Why ZYBT Stock Is in Focus Zhengye Biotechnology issued a public statement in response to unusual trading activity in its shares after a significant increase…
-

InterDigital Signs KEBA License Agreement Covering Connected EV Chargers (NASDAQ:IDCC)
The patent licensing deal expands InterDigital’s intellectual property footprint into EV charging infrastructure and the broader Internet of Things market. Key Investor Takeaways Why IDCC Stock Is in Focus InterDigital announced a new patent licensing agreement with KEBA Energy Automation GmbH, covering certain electric vehicle charging products under its global portfolio of patents related to…
-

Two Hands Advances EntangleX Quantum Platform Development for GPU-Based Circuit Simulation (USOTC:TWOH)
The company outlined new details on its in-house quantum software initiative as it continues its strategic shift toward quantum technology opportunities. Key Investor Takeaways Why TWOH Stock Is in Focus Two Hands Corporation announced continued progress on the in-house development of EntangleX, a software platform designed to simulate quantum circuits using existing graphics processing unit…
-

Kraig Biocraft CEO Highlights Spider Silk Commercialization Strategy in Just Style Interview (USOTC:KBLB)
The industry publication feature puts Kraig Biocraft’s recombinant spider silk technology and commercialization strategy in front of apparel sourcing and textile manufacturing decision-makers. Key Investor Takeaways Why KBLB Stock Is in Focus Kraig Biocraft Laboratories announced that CEO and Founder Kim Thompson has been featured in an in-depth interview with Just Style, a trade publication…
-

Intel and Fortinet Expand Cybersecurity Collaboration to Develop Security Processor 6 (NASDAQ:INTC) (NASDAQ:FTNT)
The partnership combines Intel’s semiconductor capabilities with Fortinet’s security processor expertise to accelerate next-generation cybersecurity hardware and diversify the supply chain. Key Investor Takeaways Why INTC and FTNT Stocks Are in Focus Intel and Fortinet have expanded their long-standing relationship through a strategic collaboration focused on developing Fortinet’s Security Processor 6 (SP6), the next generation…
-

VivoSim Reports First Commercial Sales in China for NAMkind Testing Services (NASDAQ:VIVS)
The company’s initial commercial programs in mainland China expand its geographic reach and mark a new step in the global rollout of its human tissue-based drug testing platform. Key Investor Takeaways Why VIVS Stock Is in Focus VivoSim announced its first commercial sales in mainland China through two paid testing programs secured by its local…
-

Jupiter Neurosciences Signs ALA-002 License Agreement Worth Up to $100 Million (NASDAQ:JUNS)
The exclusive U.S. licensing deal adds a second clinical-stage CNS asset to Jupiter Neurosciences’ pipeline, expanding its development strategy beyond its lead Parkinson’s disease program. Key Investor Takeaways Why JUNS Stock Is in Focus Jupiter Neurosciences announced it has entered into a definitive licensing agreement with PharmAla Biotech Holdings for perpetual exclusive U.S. rights to…